The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-(benzo[d][1,3]dioxol-5-yl)-3-(4-(isoindolin-5-ylamino)-4-oxobutanamido)propanoic acid ID: ALA1209692
Chembl Id: CHEMBL1209692
PubChem CID: 11975697
Max Phase: Preclinical
Molecular Formula: C22H23N3O6
Molecular Weight: 425.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CC(NC(=O)CCC(=O)Nc1ccc2c(c1)CNC2)c1ccc2c(c1)OCO2
Standard InChI: InChI=1S/C22H23N3O6/c26-20(24-16-3-1-14-10-23-11-15(14)7-16)5-6-21(27)25-17(9-22(28)29)13-2-4-18-19(8-13)31-12-30-18/h1-4,7-8,17,23H,5-6,9-12H2,(H,24,26)(H,25,27)(H,28,29)
Standard InChI Key: TYTHBXMTSPUPRQ-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 425.44Molecular Weight (Monoisotopic): 425.1587AlogP: 2.07#Rotatable Bonds: 8Polar Surface Area: 125.99Molecular Species: ACIDHBA: 6HBD: 4#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.70CX Basic pKa: 8.40CX LogP: -1.59CX LogD: -1.62Aromatic Rings: 2Heavy Atoms: 31QED Weighted: 0.51Np Likeness Score: -0.50
References 1. Krysko AA, Krysko OL, Kabanova TA, Andronati SA, Kabanov VM.. (2010) Derivatives of tetrahydroisoquinoline: synthesis and initial evaluation of novel non-peptide antagonists of the alpha(IIb)beta(3)-integrin., 20 (15): [PMID:20598885 ] [10.1016/j.bmcl.2010.06.051 ]